A study analyzing data from 389 patients undergoing porto-mesenteric vein resections with pancreatectomy found postoperative mortality at 6.4% and major complications at 32.6%. Factors such as a Charlson comorbidity index greater than 4 and preoperative treatments were significant predictors of outcomes. The research generated predictive nomograms demonstrating good potential for forecasting mortality and complications. For patients with pancreatic ductal adenocarcinoma, completion of multimodality treatment significantly improved median overall survival to 25.01 months.
Journal Article by Kapoor D, Bhandare MS (…) Shrikhande SV et 20 al. in Ann Surg Oncol
© 2025. The Author(s).